Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Completed Journey
Companies On The Road
Follow The Artist
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Completed Journey
Companies We've Met
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
2023 Nice Insight Reports
Cell & Gene Therapy: 2023 Market Analysis, CDMO Pricing and Benchmarking
Monoclonal Antibody & Recombinant Protein: 2023 Market Analysis, CDMO Pricing and Benchmarking
mRNA Vaccines & Therapeutics: 2023 Market Analysis, CDMO Pricing and Benchmarking
Sterile Drug Product: 2023 Market Analysis, CDMO Pricing and Benchmarking
Active Pharmaceutical Ingredients: 2023 Market Analysis, CDMO Pricing and Benchmarking
Antibody Drug Conjugates: 2023 Market Analysis, CDMO Pricing and Benchmarking
Contract Research Organizations: 2023 Market Analysis, Pricing and Benchmarking
Oral Solid Dosage: 2023 Market Analysis, CDMO Pricing and Benchmarking
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Avid Bioservices
23 Articles Available
Can't find what you're looking for? Try our
advanced search
.
Viral Vector Manufacturing
Considerations in Viral Vector Analytical Development to Enable Smooth Transfer to Quality Control
PAO-02-23-CL-03
Scale-Up
Scale-Up Expertise to Support Your Biologics Life Cycle
PAO-02-23-CL-06
PLIs
A Strategic Approach to Pre-License Inspections
PAO-11-022-CL-03
Viral Vectors
Risk-Based Optimization of Viral Vector Processes Adds Real Value
PAO-09-022-CL-05
Viral Vector Manufacturing
Avid Bioservices, Inc. and CRB Highlight Efforts that Enabled Opening of First Phase of New Viral Vector Facility in California in Only Eight Months
PR-M06-22-05
Capacity Expansion
Avid Bioservices Announces Further Expansion of Process Development Capacity for Mammalian Cell Business
PR-M06-22-02
Board of Directors
Driving the Industry Forward on Multiple Boards
PAO-06-22-R250-01
Viral Vector Manufacturing
Approaching Viral Vector Manufacturing With an Emphasis on Quality and Design
PAO-05-022-CL-02
Biologics CDMO
Growing as a Trusted, Dedicated Commercial Biologics CDMO
PAO-01-22-R250-02
2021 Roundup: The Year of Cell and Gene Therapy
Process Development
Shortening Biopharmaceutical Process Development Timelines with High-Throughput Approaches.
PAO-11-21-CL-02
Gene Therapy
A Customer-Centric Approach to Cell and Gene Therapy Manufacturing
PAO-10-21-CL-06
Facility Expansion
Expanding and Serving the Market with Flexible Single-Use Capacity
PAO-09-21-CL-09
Quality
Strong Quality Systems and Quality Culture Ensure Inspection-Ready Status
PAO-06-21-CL-12
Strategic Growth
Unique Commercial Experience Primes Avid Bioservices for Growth
PAO-05-21-CL-03
Biosimilars
Successful Biosimilar Development Requires an Outsourcing Partner with the Right Experience
PAO-03-21-CL-03
Single-Use Technology
Stainless Steel to Single-Use: How to Adapt to the Changing Landscape in SUT
PAP-Q4-20-CL-004
Leadership
A CEO’s Perspective: Positioning a CDMO for Significant Growth
PAP-Q3-20-CL-008
Industry Leader Insight
Accelerating COVID-19 Programs with Comprehensive Support from Cell Line to Commercial Production at a Single Site
PAP-Q2-20-CL-002
Strategic Partnership
Partnering for Success from Concept to Commercialization
PAP-Q4-19-CL-010
Contract Manufacturing
Avid Bioservices Enters into Contract Manufacturing Agreements with New and Existing Customers
PR-M07-19-NI-030
Transition
Peregrine Pharmaceuticals Announces Name Change to Avid Bioservices as Part of Transition to Dedicated Contract Development and Manufacturing Organization (CDMO)
PR-M01-18-NI-017
Drug Development
The Advantage of Having a Drug Development Company Behind Manufacturing
PTV-M06-17-BIO-010
